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relative change, particularly in individuals with low
baseline scores. Small absolute changes corresponding
to large relative differences in those with low baseline
CAC are likely to drive classiﬁcation and result in
incongruent associations with CHD risk factors. In
addition, the Hokanson and Raggi methods had worse
concordance in women than inmen. Thus, inmenwith
higher scores, there may be less dependence on spe-
ciﬁc deﬁnitions to categorize CAC progression.
In conclusion, we demonstrate that different CAC
progression deﬁnitions can result in divergent sub-
ject classiﬁcation in up to 30% of individuals, which
may alter research ﬁndings or impact individualized
clinical decisions. More research is needed to
identify which deﬁnition most closely associates
with CHD outcomes prior to the widespread appli-
cation of CAC progression as a clinical or research
tool.
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Value of CMR to Differentiate Cardiac
Angiosarcoma From Cardiac Lymphoma
Primary cardiac malignancies are extremely rare (1).
The 2 most common tumors (i.e., angiosarcoma and
lymphoma) are usually right sided and often located
near the right atrial wall and right atrioventricular
groove, hampering differentiation on cardiac imag-
ing. We describe the value of cardiac magnetic reso-
nance (CMR) in 12 patients with these tumors (7
angiosarcomas and 5 cardiac lymphomas [all B cell
non-Hodgkin, HIV negative], all conﬁrmed by biopsy
[n ¼ 11] or autopsy [n ¼ 1]). Patients with
TABLE 1 Predictors of Coronary Artery Calcium Progression and Incidence Across Different Deﬁnitions
Continuous Progression Methods Categorical Progression Methods Incidence
Absolute Log Square root Percentage Hokanson Raggi Berry Risk Categories* Incidence >0
Age     þ
Male þ þ
Total cholesterol þ þ
HDL-C   
Statin þ þ þ þ þ þ þ þ
SBP þ þ þ þ þ
Hypertension medication þ þ þ þ þ þ þ
Smoking
Fasting glucose þ þ þ þ þ þ
FHCVD þ
BMI
Baseline CAC þ  þ  þ   NA
“þ”¼ positive independent association with a p < 0.05. “–”¼ inverse independent association with a p< 0.05. Empty cells indicate absence of independent association. All models were additionally adjusted
for interscan interval. *Risk categories consist of CAC >0 to <10, 10 to <100, 100 to <400, and $400 AU.
AU ¼ Agatston unit; BMI ¼ body mass index; CAC ¼ coronary artery calcium; FHCVD ¼ family history of cardiovascular disease; HDL-C ¼ high-density lipoprotein cholesterol; NA ¼ not applicable; SBP ¼
systolic blood pressure.
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angiosarcoma were younger than patients with lym-
phoma, and dyspnea was the most common complaint
at initial presentation for both tumors. Maximal tumor
diameter was similar between the tumors (84  22 mm
for angiosarcoma vs. 88  19 mm for lymphoma). The
right atrial wall was partially to completely invaded by
tumor in all patients (Figure 1A to 1F, Online Video 1).
The right atrial appendage was involved in all patients
with an angiosarcoma but in only 1 patient with lym-
phoma (p ¼ 0.01) (Online Video 2). In contrast, all
lymphomas diffusely involved the right atrioventric-
ular groove and completely surrounded the right
coronary artery (deﬁned as >10 mm tumor tissue
around the entire circumference) (Figures 1D and 1E).
The angiosarcomas showed partial involvement of the
right atrioventricular groove in 4 patients and only
incompletely (<180) encased the right coronary
artery (RCA) (p < 0.001) (Figure 1A). Extension toward
the right ventricle was present in all lymphomas but
only in 3 of 7 angiosarcomas (Figures 1D and 1E). The
tricuspid valve was involved occasionally and was no
different between groups. The CMR images showed
a central liquefaction necrosis (or necrotic areas) in
6 of 7 angiosarcomas (i.e., rim enhancement with
lack of central enhancement) (Figure 1C). This pattern
was absent in all lymphomas that showed homoge-
neous tumor enhancement (p ¼ 0.015) (Figure 1F).
Pericardial effusion was common in both conditions
(5 of 7 angiosarcomas [range 10 to 30 mm] and 4 of 5
lymphomas [range 27 to 45 mm]) (Figures 1D and 1F).
Except in 1 patient with angiosarcoma, enhancement
of the pericardial layers was shown on post-contrast
CMR images in all patients. Pericardial “nodular”
metastasis (including the transverse/oblique sinus)
was present about one-half of the time in both con-
ditions, whereas pulmonary metastases were found
only in angiosarcomas (3 of 7 patients).
The current results obtained in a small but repre-
sentative group of patients with cardiac angio-
sarcoma and HIV-negative lymphoma showed that
FIGURE 1 Representative Examples of Cardiac Angiosarcoma and Cardiac Lymphoma
(A to C) Cardiac angiosarcoma. (D to F) Cardiac lymphoma. Axial T1-weighted fast-spin-echo cardiac magnetic resonance (CMR) (A and D). Axial
T2-weighted short-tau inversion-recovery fast-spin-echo CMR (B and E). Axial late gadolinium enhancement (LGE) CMR (C) and T1-weighted
fast-spin-echo CMR post-contrast (F). The angiosarcoma presents as a voluminous mass (A, arrowheads) arising from the right atrial wall
extending to the pericardium, right atrial cavity, and right coronary artery (A, arrow) with strong rim enhancement (C, arrows) and central
liquefaction (C, asterisk) on LGE CMR (Online Video 1). The cardiac lymphoma presents as a mass mainly centered in the right atrioventricular
groove (D, arrowheads), diffusely surrounding the right coronary artery (D, arrow), extending to the right atrial and right ventricular wall
(Online Video 2). Homogeneous enhancement post-contrast administration (F). Also note the presence of a circumferential pericardial effusion
(F, asterisk).
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CMR can help differentiate between these malignant
tumors. Tumor location in the right atrial wall and
atrial appendage in a younger patient with central
necrosis and possibly pulmonary metastasis favors
angiosarcoma, whereas lymphomas appear in older
patients with diffuse right atrioventricular involve-
ment and RCA encasement and as solid tumors on
CMR imaging. Although this is a small sample and
features may depend on when the diagnosis was
made in the natural history of the disease, it repre-
sents a signiﬁcant number of biopsy-proven tumors
with CMR correlation in these rare conditions.
CMR may help noninvasive differentiation between
angiosarcoma and lymphoma.
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APPENDIX For accompanying videos and their legends, please see
the online version of this article.
Diagnostic Accuracy of Rapid Kilovolt
Peak–Switching Dual-Energy CT Coronary
Angiography in Patients With a High
Calcium Score
Beam-hardening artifacts resulting from heavily
calciﬁed plaques in patients with a high coronary
calcium score (CCS) may reduce coronary computed
tomography angiography (CTA) diagnostic accuracy
of the increased false-positive rate (1). A recently
introduced computed tomography (CT) technology
combines dual-energy computed tomography (DECT)
with the latest gemstone detectors, made by a com-
plex rare earth–based oxide that has a chemically
replicated garnet crystal structure for gemstone
spectral imaging (GSI) integrated into a 64-slice
scanner (1). The scanner is equipped with an x-ray
source that can switch energy rapidly. The datasets
obtained from 2 different energies allow the recon-
struction of material decomposed images (MDIs).
Two studies demonstrated that coronary CTA using
the new DECT offers improvement in terms of image
quality compared with standard single-energy CT
(1,2). The aim of the present study was to evaluate in
patients with a high CCS (>400) the diagnostic
accuracy of coronary CTA using DECT with mono-
chromatic images and calcium removal by MDI
compared with simulated conventional poly-
chromatic image evaluation as a simulated standard
of reference (sSTD) and compare the results with
invasive coronary angiography (ICA). We enrolled 75
patients with indication for nonemergent ICA for
suspected coronary artery disease (CAD), a CCS
higher than 400, and a heart rate of #65 beats/min.
Coronary CTA was performed with GSI-capable CT
(Discovery HDCT 750, GE Healthcare, Milwaukee,
Wisconsin) and the followings parameters: 64 
0.625 mm and gantry rotation time of 0.35 s. Cardiac
GSI can simultaneously acquire data by rapidly
switching between 80 kVp and 140 kVp energies
in <0.252 ms, which produces data that contain
minimal misregistration artifacts. The beam was kept
at 140 kVp for only a fraction (about one-third) of the
radiation time to keep the radiation dose low, whereas
during two-thirds of the scan time, the beam was
switched to a lower tube current peak (80 kVp). A tube
current of y600 mA was used. All scans were per-
formed with prospectively electrocardiography-
triggered acquisition. First, from the acquired DECT
data, conventional polychromatic images that corre-
sponded to a peak tube voltage ranging between
standard values of 100 kV and 120 kV were simu-
lated using a 77-keV monochromatic image and used
as an sSTD. Second, MDI (iodine minus calcium)
derived from the GSI data were used to represent the
GSI. The Adaptive Statistical Iterative Reconstruc-
tion (ASIR) post-processing algorithm (set at 40%)
was used for both types of image reconstruction
(sSTD and GSI). The pre-test probability of CAD was
intermediate to high (62%). Accordingly, the preva-
lence of obstructive CAD was 68% (51 of 75 patients).
Of patients with $50% stenosis, 31 (61%) had mul-
tivessel CAD. The mean CCS was 606  253. Eighty
percent of patients were pre-treated with intrave-
nous metoprolol before scanning, achieving a mean
heart rate of 59  5 beats/min. The mean effective
dose was 0.87 mSv for CCS and 3.92 mSv for coro-
nary CTA. The number of coronary segments with
excellent image quality was signiﬁcantly higher with
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